Some additional analytical results suggest that P53 can induce the transcription of MDM2, while MDM2 is a negative regulator of P53, and that NFκB’s activation is not a necessary checkpoint that the cancer cell should go through on the path to proliferation and immortality. Here, MDM2 is linked to cancer.